Picture EBD Group Biotech Showcase 2024 San Francisco 650x100px

Document › Details

Microsaic Systems plc. (4/10/18). "Press Release: Microsaic Systems Launches 4500 MiD for Point-of-need Mass Spectrometry at Analytica 2018".

	Region	München (Munich)
	Country	Germany
	Organisation	Microsaic Systems plc (AIM: MSYS)
	Organisation 2	N+1 Singer (Group)
	Product	4500 MiD® desktop MS system
	Product 2	Analytica 2018 München (Munich)
	Person	Tracey, Glenn (Microsaic 201709– CEO joined 201503 as COO before Cambridge Temperature Concepts + PerkinElmer)
	Person 2	Metcalf, Bevan John (Microsaic 201512– Finance Director before Beowulf Mining + Afferro + African Eagle + Orion + GSK)

Microsaic Systems, Hall A3 Booth 422B, Analytica 2018, Munich, Germany, 10-13 April 2018

Leaders in miniaturised mass spectrometer detection instruments and technologies, Microsaic Systems (AIM: MSYS) has announced the launch of its latest chip-based mass spectrometer at Analytica 2018 (Hall A3, booth 422B). Designed for point-of-need analysis, the 4500 MiD® can be installed where no other mass spectrometer can be deployed, all while retaining the performance of a conventional mass spectrometry (MS) system.

Offering a one box solution for MS detection, Microsaic uses chip-based miniaturisation technology to provide agile sample detection and identification at the point of use. This allows end users to make quick decisions in real-time to optimise overall productivity.

The company’s latest innovation, the 4500 MiD® combines the vacuum system, electronics and computer inside on box, with no need for a floor pump. Reliable, robust and user friendly, the new system boasts an increased mass range, a completely tool-less front-end for enhanced control, and an intuitive user interface. In addition, a change in front-end alignment has also strengthened system uptime while reducing the deposition of contaminants downstream.

Easy to operate and maintain, users don’t require any prior MS knowledge as the 4500 MiD® system is simple to set up and use. It also offers reduced solvent, nitrogen and power consumption to lower operating costs and provide a greener solution for mass detection.

Glenn Tracey, CEO, commented: “Developed from customer feedback and market analysis, the 4500 MiD® opens up even more applications for point-of-need mass spectrometry, including for larger biological molecules, such as peptides and small proteins.

“With over 60 patents to date, we’re committed to further developing miniaturised mass spectrometry to bring the benefits of robust point-of-need analysis to biologics detection. A range of biological entities, such as monoclonal antibodies, can now be analysed by our technology in just minutes. This has a significant and very positive impact on biologic manufacturing productivity, and we are working with some of the foremost companies in the field.”

For more information visit Hall A3 Booth 422B at Analytica 2018, or www.microsaic.com

For more information, please contact:

Microsaic Systems plc
Glenn Tracey, COO
Bevan Metcalf, FD
+44 (0) 1483 751577

IFC (Financial PR)
Graham Herring
Heather Armstrong
Florence Chandler
+44 (0)20 7638 9571

N+1 Singer (Nominated
Adviser & Broker)
Shaun Dobson
Liz Yong
+44 (0) 20 7496 3000

Record changed: 2023-06-05